We were able to induce FasL expression on 12.9% of CXCR6+CD8+ T cells, which led to killing 50% of hepatoma cells, indicating each cell has the potential to kill multiple (in our model, 3–4, over 24 hours) hepatocytes. The gene discussed is CD8A; the disease is hepatocellular carcinoma.